These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11507953)

  • 1. [Multiresistant tuberculosis in the Czech Republic in 1998 and causes of its occurrence].
    Krejbich F; Trnka L; Danková D
    Cas Lek Cesk; 2001 Jun; 140(13):409-10. PubMed ID: 11507953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis in the Czech Republic in the year 2004].
    Homolka J; Krejbich F; Mazánková V
    Cas Lek Cesk; 2005; 144(9):587-91. PubMed ID: 16193935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tuberculosis among foreigners in the Czech Republic 2003-2006].
    Homolka J; Krejbich F
    Cas Lek Cesk; 2008; 147(3):155-8. PubMed ID: 18401981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC11A1 (formerly NRAMP1) polymorphisms associated with multidrug-resistant tuberculosis.
    Takahashi K; Hasegawa Y; Abe T; Yamamoto T; Nakashima K; Imaizumi K; Shimokata K
    Tuberculosis (Edinb); 2008 Jan; 88(1):52-7. PubMed ID: 17950034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis in the Czech Republic during 2006].
    Homolka J; Krejbich F; Holub J
    Cas Lek Cesk; 2007; 146(9):681-6. PubMed ID: 17966191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.
    Jugheli L; Rigouts L; Shamputa IC; Bram de Rijk W; Portaels F
    Int J Tuberc Lung Dis; 2008 May; 12(5):561-6. PubMed ID: 18419893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multi-drug-resistant tuberculosis in a Department of Infectious Diseases].
    Constant CA; Ferreira PB; Valadas E; Antunes F
    Acta Med Port; 2004; 17(2):157-66. PubMed ID: 15921647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant tuberculosis in a low-incidence region shows a high rate of transmission.
    Vázquez-Gallardo R; Anibarro L; Fernández-Villar A; Díaz-Cabanela D; Cruz-Ferro E; Pérez del Molino ML; Túñez V; Samper S; Iglesias MJ
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):429-35. PubMed ID: 17394690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of drug resistance and transmission of tuberculosis in an urban community.
    Telles MA; Ferrazoli L; Waldman EA; Giampaglia CM; Martins MC; Ueki SY; Chimara E; Silva CA; Cruz V; Waldman CC; Heyn I; Hirono IU; Riley LW
    Int J Tuberc Lung Dis; 2005 Sep; 9(9):970-6. PubMed ID: 16158889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for multidrug-resistant tuberculosis in Hong Kong.
    Law WS; Yew WW; Chiu Leung C; Kam KM; Tam CM; Chan CK; Leung CC
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1065-70. PubMed ID: 18713506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
    Ormerod LP
    Br Med Bull; 2005; 73-74():17-24. PubMed ID: 15956357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In the European Union, TB patients from former Soviet countries have a high risk of multidrug resistance.
    Falzon D; Infuso A; Aït-Belghiti F
    Int J Tuberc Lung Dis; 2006 Sep; 10(9):954-8. PubMed ID: 16964783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of treatment of multiresistant tuberculosis].
    Bártů V; Hricíková I; Kopecká E; Vasáková M
    Cas Lek Cesk; 2003; 142(4):226-8. PubMed ID: 12841125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan].
    Toyota E; Kawabe Y; Yotsumoto H; Sakatani M; Tsuyuguchi K; Maekura R; Fujikawa K; Takashima T; Ogawa K; Yoshiyama T; Sugie T
    Kekkaku; 2008 Dec; 83(12):773-7. PubMed ID: 19172822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of multidrug-resistant tuberculosis in Italy.
    Ferrara G; Richeldi L; Bugiani M; Cirillo D; Besozzi G; Nutini S; Casali L; Fiorentini F; Codecasa LR; Migliori GB
    Int J Tuberc Lung Dis; 2005 May; 9(5):507-13. PubMed ID: 15875921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefining MDR-TB transmission 'hot spots'.
    Becerra MC; Bayona J; Freeman J; Farmer PE; Kim JY
    Int J Tuberc Lung Dis; 2000 May; 4(5):387-94. PubMed ID: 10815730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis.
    Bayona J; Chavez-Pachas AM; Palacios E; Llaro K; Sapag R; Becerra MC
    Int J Tuberc Lung Dis; 2003 Dec; 7(12 Suppl 3):S501-9. PubMed ID: 14677844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.